Evaxion Biotech AS News - EVAX

Company Name	Stock Ticker Symbol	Market	Type
Evaxion Biotech AS	EVAX	NASDAQ	Depository Receipt

	Price Change	Change Percent	Stock Price	Last Traded
	-0.017	-2.0%	0.833	00:00:11

Open Price	Low Price	High Price	Close Price	Prev Close
0.899	0.8113	0.899	0.833	0.85

more quote information »

Recent News

Date	Time	Source	Heading
9/27/2023	16:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/25/2023	16:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/20/2023	08:26	GLOBE	Evaxion Partners With Pharmaceutical Company Afrigen..
9/18/2023	08:23	GLOBE	Evaxion expands preclinical bacterial vaccine pipeline in..
9/13/2023	16:45	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
9/11/2023	08:17	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/2023	08:17	GLOBE	Revolutionizing Vaccine Discovery: New Data Validates..
9/07/2023	16:45	EDGAR2	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
8/31/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/29/2023	09:22	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/29/2023	08:30	GLOBE	Evaxion announces Executive Management Changes to strengthen..
8/25/2023	17:00	EDGAR2	Form POS AM - Post-Effective amendments for registration..
8/18/2023	11:57	GLOBE	Evaxion Announces Business Update and Second Quarter 2023..
8/18/2023	09:28	EDGAR2	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
8/17/2023	16:58	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/17/2023	16:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/11/2023	16:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/2023	16:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/2023	07:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/2023	07:00	GLOBE	Evaxion announces financing commitments totaling up to USD..
7/31/2023	16:45	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/31/2023	07:00	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/31/2023	07:00	GLOBE	Evaxion presents promising results on EVX-B1, an AI-designed..
7/11/2023	09:14	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/03/2023	17:00	GLOBE	Evaxion’s AI technology identifies cancer vaccine targets..
5/31/2023	08:30	GLOBE	Evaxion Announces Business Update and First Quarter 2023..
5/25/2023	17:00	GLOBE	Evaxion unveils proprietary genetic adjuvant technology to..
5/16/2023	05:46	GLOBE	Evaxion to host R&D Day on May 25, 2023
4/13/2023	09:44	GLOBE	Evaxion and Pennsylvania State University publish..
3/28/2023	07:46	GLOBE	Evaxion Announces Increased Focus and Fast-Tracking of its..
3/23/2023	07:55	GLOBE	Evaxion presents a new source of AI-derived..
3/14/2023	16:30	GLOBE	Evaxion Biotech to announce clinical data for the..
2/08/2023	06:30	GLOBE	Evaxion and Pantherna announce promising preclinical mRNA..
1/19/2023	08:45	GLOBE	Evaxion receives FDA fast-track designation for personalized..
1/03/2023	07:30	GLOBE	Evaxion receives approval from FDA to proceed with the..
12/15/2022	07:48	GLOBE	Evaxion to present a full clinical readout on two..
12/06/2022	02:00	GLOBE	Evaxion and ExpreS²ion initiate research collaboration on a..
11/17/2022	06:59	GLOBE	Evaxion announces promising results from Phase 1/2a clinical..
11/14/2022	07:13	GLOBE	Evaxion Announces Third Quarter 2022 Financial Results and..
11/10/2022	04:09	GLOBE	Evaxion CEO comments on strategic focus
10/05/2022	08:32	GLOBE	Evaxion welcomes Per Norlén as new CEO.